| Pfizer AG - Sutent 25 mg, Hartkapseln | | 57563 | | 02 | | Sutent 25 mg | | Hartkapseln | | L01EX01 | | Sunitinib | | 28.04.2006 | | |
| | Composition | | sunitinibum 25 mg ut sunitinibi malas, mannitolum, carmellosum natricum conexum, povidonum K 25, magnesii stearas, Kapselhülle: gelatina, E 172 (rubrum), E 171, E 172 (flavum), E 172 (nigrum), Drucktinte: lacca, propylenglycolum, natrii hydroxidum, povidonum, E 171, pro capsula corresp. natrium 0.36 mg. | | Packungsbestandteile | | Capsules | | | | | | | | Principe actif | Concentr. |
|---|
| Sunitinib | 25 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Sunitinib | 25 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | (Nigrum) | | | | (Rubrum) | | | | Carmellosum Natricum Conexum | | | | E 171 | | color. | | E 172 | | color. | | Gelatina | | Kapselhülle | | Lacca | | Drucktinte | | Magnesii Stearas | | | | Mannitol | | | | Sodium Hydroxide | | | | Povidone | | | | Povidonum K | 25 | | | Propylenglycol | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 005 | 28 Gélule(s) | 1761.64 | 1922.45 | A | LS | Oui |
|
|
